C12N 9/1276
Rna-directed dna polymerase , i.e. reverse transcriptase or telomerase
Official title: {RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase}
C12N9/1276 (Rna-directed dna polymerase , i.e. reverse transcriptase or telomerase) appears on 558 US grants and 872 published applications in this corpus.
Search patents in C12N- Granted patents
- 558
- Published applications
- 872
- Assignees
- 360
- Inventors
- 1,572
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 7 | 0 |
| 1995 | 14 | 0 |
| 1996 | 10 | 0 |
| 1997 | 27 | 0 |
| 1998 | 38 | 0 |
| 1999 | 17 | 0 |
| 2000 | 15 | 0 |
| 2001 | 13 | 0 |
| 2002 | 14 | 20 |
| 2003 | 20 | 50 |
| 2004 | 12 | 28 |
| 2005 | 7 | 22 |
| 2006 | 15 | 18 |
| 2007 | 10 | 19 |
| 2008 | 5 | 11 |
| 2009 | 9 | 14 |
| 2010 | 8 | 20 |
| 2011 | 10 | 22 |
| 2012 | 9 | 10 |
| 2013 | 6 | 20 |
| 2014 | 17 | 23 |
| 2015 | 15 | 24 |
| 2016 | 15 | 35 |
| 2017 | 28 | 30 |
| 2018 | 26 | 27 |
| 2019 | 16 | 22 |
| 2020 | 17 | 25 |
| 2021 | 18 | 38 |
| 2022 | 19 | 51 |
| 2023 | 20 | 70 |
| 2024 | 33 | 100 |
| 2025 | 30 | 98 |
| 2026 | 25 | 75 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Prime editor system for in vivo genome editing6 Oct 2026US 12,753,397 B2University of Massachusetts
- Inactive telomerase, adenovirus associated virus and artificial mRNA having same and use thereof22 Sep 2026US 12,742,161 B2Nanjing Juvensis Therapuetics Co., Ltd.
- Recombinant adeno-associated viral vectors for delivering a therapeutic gene to lungs30 Jun 2026US 12,668,817 B1Telomere Therapeutics S.L.
- Methods of treating or preventing age-related disorders16 Jun 2026US 12,653,907 B2Bioviva USA Inc.
- Reverse transcriptase with improved properties8 Oct 2026US 2026/0308541 A1
- Transcriptional recording by crispr spacer acquisition from rna1 Oct 2026US 2026/0297595 A1ETH Zurich
- Recombinant enzyme for the accurate insertion of dna sequences in eukaryotic cells1 Oct 2026US 2026/0297624 A1Rensselaer Polytechnic Institute
- Prime editing of single base mutations in sickle cell disease17 Sep 2026US 2026/0273102 A1Beam Therapeutics Inc.
- Strand-displacing dna polymerases17 Sep 2026US 2026/0275306 A1Varigen Biosciences Corporation
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Purified thermostable enzyme619US 4,889,818 ACetus Corporation · 1989
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Reverse transcription with thermostable DNA polymerases - high temperature reverse transcription301US 5,322,770 AHoffman-LaRoche Inc. · 1994